1.Alternative Name:LEU-9,Tp40;CD7 antigen (p41); CD7 antigen; CD7 molecule; CD7; GP40T-cell surface antigen Leu-9; LEU-9; T-cell antigen CD7; T-cell leukemia antigen; Tp40; TP41; TP41p41 protein
2.Target:CD7
3.Source:Human CD7 was expressed from HEK293 with poly His at the C-terminal
4.Sequence:Ala26-Pro180
5.Protein structure:P09564His
6.Molecular Characterization:The protein has a calculated MW of 18kDa.The reducing (R) heterodimer protein migrates as 40-60 kDa due to glycosylation
7.Purity:SDS-PAGE>95%，SEC>95%
8.Reconstitution:sterile H2O
9.Endotoxin:<1EU/mg
10.Formulation:Lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
Note:For research use only .


11.SDS-PAGE

Determined by SDS-PAGE, the purity of the protein is greater than 90%.

12.SEC-HPLC

Determined by SEC-HPLC, the purity of the protein is greater than 90%.

13.ELISA

When Recombinant Human CD7/His Protein is immobilized at 2μg/mL (100 μL/well), the concentration of Anti-Human CD7 antibody that produces 50% of the optimal binding response is approximately 30 ng/ml.